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Background: The plant Laggera aurita is an annual or biannual plant belonging to the family Compositae that has 
been used for management of pain related conditions locally.  It reportedly has anti-oxidant as well as antimicrobial 
properties. 
Objectives: To conduct LD50 and phytochemical studies, evaluate the analgesic and anti-inflammatory properties of 
the methanol extract of L. aurita and determine possible mechanism of action.  
Methodology: Analgesic and anti-inflammatory properties of the extract were investigated using acetic acid induced 
writhing, thermally-induced pain, and formalin induced inflammation in rats and mice. Phytochemical and acute 
toxicological screenings were also conducted.  
Results: The LD50 was found to be above 5000 mg/kg with slight changes in histological architecture observed in the 
kidney, liver, lungs and stomach. The extract at dose 200, 400 and 800 mg/kg significantly (p<0.05) inhibited acetic 
acid induced writhes in mice and increased mean reaction time in the thermal pain model, both dose dependently. The 
effect on thermally induced pain was blocked by naloxone, a non-specific opioid antagonist, suggesting opioid 
receptor involvement in analgesia. The extract also significantly (p<0.05) decreased formalin induced paw edema 
dose dependently.  
Conclusion: These findings suggest that the methanol extract of L. aurita possesses analgesic and anti-inflammatory 
properties that justify its ethnomedicinal use in management of pain and inflammation. 
Keywords: Laggera aurita, anti-inflammatory, analgesic, acute toxicity. 
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1. Introduction 
The use of herbal drugs in the treatment of pain is a 
common practice in many African countries (Usman et 
al. 2008). Despite the immense technological 
advancement in modern medicine, many people in 
developing countries still rely on traditional medicine 
and healing practices for their daily health care needs 
(Gedif and Hahn, 2003). The Plant L. aurita (Linn F) 
belongs to the family Compositae. It is called 
Abanaadene (vulture’s excrement) in Igbo (Awka) and 
Eru-taba (Slave of tobacco) in Yoruba (Ilorin) (Burkill, 
1985). L. aurita is a widely used medicinal plant in 
African countries like Nigeria, Senegal and Ghana. The 
plant was also listed among anti tubercular plants of 
foreign origin (Vikrant, 2011). The anti-oxidant and 
antibacterial activities of the steam distilled volatile oil 
of L. aurita grown in Pakistan have been reported 
(Shahwar et al. 2012). Recent studies on the ethanol 
crude extract of L. aurita showed the presence of 
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triterpenes, saponins, flavonoids, coumarins, tannins 
and also anti-inflammatory effects (Abdulla et al. 2013). 
Olurishe and Mati, (2014) reported some preliminary 
antihyperalgesic potentials. The current study was 
conducted to investigate the acute toxicological and 
anti-nociceptive effect of the methanol extract of L. 
aurita using rodent models. 
2. Materials and Methods 
2.1 Plant Collection 
The whole plant was collected from Zaria, Kaduna State 
in December, 2012. The plant specimen was identified 
at the Herbarium Unit, Department of Biological 
Sciences, Ahmadu Bello University Zaria- Nigeria by 
comparing with a specimen voucher number 510 
previously deposited in the herbarium.  
2.2 Extraction Procedure 
The plant material was dried under shade with 
intermittent weighing until a constant weight was 
obtained. The stalk part of the plant was removed and 
whole plant was size-reduced using mortar and pestle. 
About 1500 grams of the powdered materials was 
extracted with methanol using soxhlet apparatus at a 
temperature of 65 °C. The extract was concentrated 
under reduced pressure and temperature 45 °C. The 
extract was then stored in a dessicator until required 
for each study. 
2.3 Animals 
Wistar strain rats (150-200 grams) and swiss albino 
mice (20-25 grams) of either sex were obtained from 
the Animal House Facility of the Department of 
Pharmacology and Therapeutics, Ahmadu Bello 
University Zaria, Nigeria. They were housed in standard 
propylene cages and kept under natural day and light 
cycle. The animals were fed on standard laboratory 
animal diet and water ad libitum. Food was withdrawn 
during the experimental hours to verify 
pharmacological outcomes. All experimental protocols 
were approved by the University Animal Ethics 
Committee. 
2.4 Drugs  
Acetic acid (Ranbaxy Laboratories Ltd, Punjab); 
Ketoprofen (Lek; Slovenia); Piroxicam (Pfizer 
laboratories, Pakistan); Naloxone (Pfizer laboratories, 
Pakistan); Morphine sulphate BP (Martindale 
Pharmaceuticals, Ramford, Essex). All drugs or reagents 
were freshly prepared to the desired concentration with 
distilled water or normal saline just before use. 
2.5 Phytochemical Screening of Laggera aurita 
Phytochemical screening was carried out on the 
methanol extract of the plant L. aurita using standard 
protocol as described by Trease and Evans (1983).  
2.6 Acute Toxicity Studies in Mice and Rats (LD50) 
LD50 determination was conducted using Organization 
for Economic Co-operation and Development (OECD 
420) guidelines in rats and mice. In this method, two 
groups each of three animals were fasted prior to 
dosing (food but not water was withheld overnight for 
the rats and for 3 hours for mice). The fasted body 
weight was determined for each animal and the dose 
was then calculated according to the body weight. Food 
was further withheld for 3-4 hours in rats and 1-2 hours 
in mice after the extract was administered. The extract 
was administered in a single oral dose using an oral 
canula. A start dose of 2000 mg/kg was used for each 
animal in the first phase. Animals dosed in the first 
phase were observed for 48 hours after which there 
was no death and the test proceeded to the second 
phase. The same procedure was adopted but with a 
dose of 5000 mg/kg. 
Animals were observed individually at least once during 
the first 30 minutes after dosing and periodically during 
the first 24 hours with careful observation during first 4 
hours, and then daily for 14 days. Observations included 
changes in skin and fur, eyes and mucous membranes, 
somator activity and behaviour pattern, autonomic and 
central nervous systems. Animals were also observed 
for tremors, convulsions, salivation, diarrhoea, lethargy, 
sleep and coma, with onset of toxic symptoms and 
disappearance also noted. Individual weights of animals 
were determined at least weekly. At the end of the test, 
surviving animals were weighed and then euthanized 
using chloroform. The liver, kidney, spleen, lungs, heart 
and stomach of the animals were harvested fresh and 
fixed in 10% v/v formalin for histological observations. 
2.7 Histological studies 
Tissues were prepared and slides were examined 
microscopically for pathological lesions as described by 
Arthur and John (1978). 
2.8 Antinociceptive Studies 
Acetic acid induced writhing test 
The acetic acid induced writhing test in mice as 
described by Koster et al. (1959) was employed. Thirty 
albino mice were divided into five groups of six mice. 
The first group received 10 ml/kg of normal saline 
orally and this served as control. Group 2 received 
Piroxicam 20 mg/kg as positive control. Group 3, 4 and 
5 received 200, 400 and 800 mg/kg oral doses of the 
methanol extract of Laggera aurita (MELA) 
respectively. Thirty minutes after pretreatment, mice in 
all groups were treated with acetic acid (0.6% v/v, 10 
ml/kg body weight i.p.). Mice were then placed in 
individual cages and the number of abdominal writhes 
was counted for each mouse for a period of 10 minutes 
after 5 minutes latency period. 
Hot plate test in mice  
The method previously described by Eddy and 
Leimbach (1953) was employed for the   study. Mice 
were grouped into five groups of six mice each. Group 1 
received 10 ml/kg normal saline orally. Groups 2, 3 and 
4 received 200, 400 and 800 mg/kg of MELA orally 
respectively, while group 5 received 5 mg/kg  morphine 
solution orally. Thirty minutes after treatment, each 
mouse was placed on a hot plate (Gallenkamp 
thermostat) which was set and maintained at 55 ± 1oC. 
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The pain response latency was determined using a stop 
watch. 
Effect of naloxone pretreatment on analgesic effect 
of methanol extract of Laggera aurita in the 
thermally induced pain model 
Four groups of 10 mice each were used. Initially all the 
animals received naloxone at a dose of 2 mg/ kg i.p. 
After 15 minutes, group 1 and 2 received 400 and 800 
mg/ kg of MELA orally. Group 3 received normal saline 
10 ml/kg orally and group 4 received morphine 5 mg/ 
kg orally. The index of pain response latency was 
assessed at 60, 120 and 180 minutes using hot plate 
method (Younos et al. 1990). 
2.9 Anti-inflammatory activity 
Formalin induced inflammation 
Thirty rats were divided into five groups each of six 
rats. Group 1 was treated with 10 ml/kg normal saline 
orally; group 2 was treated with 10 mg/kg ketoprofen 
orally; while group 3, 4 and 5 received 200, 400 and 800 
mg/kg of MELA respectively orally. Inflammation was 
induced in rat hind paw by injecting formalin 0.1 ml 
(1% w/v in 0.9% normal saline) into the subplanter 
surface of the left hind paw 30 mins after treatment. 
Paw thickness (mm) was measured using a digital 
vernier caliper (MR 2002) at 0, 1, 2, 3, 4 and 5 hours 
after formalin injection (Winter et al. 1963).  
2.10 Data Analysis  
The results were expressed as Mean ± SEM and 
analyzed using one way ANOVA for acetic acid test and 
repeated measures ANOVA for hot plate test, interaction 
of extract with naloxone, and formalin induced 
inflammation, followed by Bonferoni post hoc test. 
Results were considered significant at P ≤0.05. 
3.  Results and Discussion 
3.1 Phytochemical screening 
The phytochemical constituents found in the methanol 
extract of L. aurita include the flavonoids, alkaloids, 
glycosides, saponins, cardiac glycosides, phenols, 
tannins, steroids and carbohydrates.  
3.2 Acute Toxicity Study 
The oral acute toxicity (LD50) was found to be greater 
than 5000 mg/kg body weight in both mice and rats. 
Histological studies 
Liver: The groups that received normal saline showed 
normal hepatocytes and intact portal tract in both mice 
and rats. At 2000 mg/kg of the methanol extract of 
L.aurita (MELA), there was slight vascular congestion in 
mice and there was intense vascular damage with 
kupffer cell hyperplasia and slight hepatic necrosis in 
rats. At 5000 mg/kg of MELA, there was intense 
vascular congestion with kupffer cell hyperplasia and 
lymphocyte hyperplasia in mice (Plate I) and there was 
vascular congestion with lymphocyte hyperplasia in 
rats (Plate II). 
Kidneys: The normal saline group showed normal renal 
tissue, normal glomeruli, tubular epithelium, interstitial 
tissue and vessels. At 2000 mg/kg of MELA, there was 
slight glomerular necrosis in mice, slight glomerular 
necrosis and tubular distortion in rats. At 5000 mg/kg, 
there was slight glomerular necrosis with tubular 
damage in mice (Plate III) and rats (Plate IV). 
Lungs: The saline groups showed normal alveoli in both 
mice and rats. At 2000 mg/kg, alveoli were normal in 
both mice and rats. At 5000 mg/kg, there was slight 
alveoli congestion in mice (Plate V), while vacuotation 
with lymphocyte hyperplasia and congestion were 
observed in rats (Plate VI). 
Spleen: The saline group and at 2000 mg/kg extract, 
red and white pulp in both mice and rats were normal. 
At 5000 mg/kg there was lymphocyte hyperplasia 
(Plate VII). 
Stomach: The normal saline group showed normal 
mucosa lining in both mice and rats. At 2000 mg/kg, 
both mice and rats showed normal mucosa lining. At 
5000 mg/kg, moderate erosion of stomach epithelium 
in mice and slight mucosa damage in rats (Plate VIII) 
were observed. 
Heart: Cardiac muscles in both mice and rats were 
normal in the normal saline group, at 2000 mg/kg and 
5000 mg/kg of MELA. 
3.2 Analgesic activity 
Effect of methanol extract of L. aurita on acetic acid 
induced writhes test in mice 
MELA significantly (p<0.05) decreased the number of 
acetic acid-induced writhes in mice in a dose dependent 
manner. The effect of MELA at all doses tested showed 
significant (p<0.01) decrease in number of acetic acid-
induced writhes than piroxicam at a dose of 20 mg/kg 
(Figure 1). 
Effect of the methanol extract of L. aurita on 
thermally induced pain 
MELA significantly (p<0.05) increased the mean 
reaction time in a dose dependent manner. At 800 
mg/kg, MELA showed significant (p<0.01) increase in 
mean reaction time than morphine (5 mg/kg) at three 
and four hours treatment time (Table 1). 
Effect of methanol extract of L. aurita interacted 
with naloxone and assessed by hot plate test 
MELA co-administered with naloxone significantly 
(p<0.01) decreased the reaction time in a dose 
dependent manner. At 800 mg/kg, MELA showed 
significant (p<0.001) decrease in reaction time than 
morphine 5 mg/kg at the three hours treatment time 
(Table 2). 
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Plate I: Photomicrograph of a liver section of mouse treated 
with 5000 mg/kg of methanol extract of L. aurita and 
observed for fourteen days showing A = intense vascular 
congestion, B = Kupffer cell hyperplasia, C = lymphocyte 
hyperplasia. H & E stain (× 400) 
Plate II: Photomicrograph of a liver section of rat treated 
with 5000 mg/kg of methanol extract of L. aurita and 
observed for fourteen days showing A = vascular congestion, 
B = lymphocyte hyperplasia. H & E stain (× 400) 
 
 
 
 
  
Plate III: Photomicrograph of a kidney section of mouse 
treated with 5000 mg/kg of methanol extract of L. aurita and 
observed for fourteen days showing A = slight glomerular 
necrosis, B = tubular damage. H & E stain (× 400) 
Plate IV: Photomicrograph of a kidney section of rat treated 
with 5000 mg/kg of methanol extract of L. aurita and 
observed for fourteen days showing A = slight glomerulus 
necrosis, B = tubular damage. H & E stain (× 400) 
 
3.3 Anti-inflammatory activity 
Effect of the methanol extract of L. aurita on 
formalin induced inflammation in rats 
Formalin (0.6% v/v) produced local edema in rats paw 
which was significant as compared to time zero in all 
the groups (p<0.001). The red color denote peak of 
edema and blue color denotes significant statistical 
decrease in mean paw edema size. Peak of inflammation 
was reached in the third hour in normal saline and 
extract dose 200 mg/kg, and in the second hour for 
Ketoprofen 10 mg/kg, MELA 400 and 800 mg/kg. The 
extract significantly (p<0.001) decreased formalin-
induced paw edema dose dependently at the fourth and 
fifth hours post treatment time (Table 3). 
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Plate V: Photomicrograph of a lung section of mouse treated 
with 5000 mg/kg of methanol extract of L. aurita and 
observed for fourteen days showing A = slight alveoli 
congestion. H & E stain (× 400) 
Plate VI: Photomicrograph of a lung section of rat treated 
with 5000 mg/kg of methanol extract of L. aurita and 
observed for 14 days showing A = vacuotation, B = 
lymphocyte hyperplasia, C = congestion. H & E stain (× 400) 
 
 
 
 
 
  
Plate VII: Photomicrograph of a spleen section of mouse 
treated with 5000 mg/kg of methanol extract of L. aurita and 
observed for fourteen days showing A = lymphocyte 
hyperplasia. H & E stain (× 400) 
Plate VIII: Photomicrograph of a stomach section of rat 
treated with 5000 mg/kg of methanol extract of L. aurita and 
observed for fourteen days showing A = slight mucosa 
damage. H & E stain (× 400) 
 
4. Discussion 
The biological or pharmacological actions of plant 
extracts are known to be due to the presence of specific 
phytochemical constituents. Analgesic and anti-
inflammatory effects have been observed and reported 
with flavonoids (Amin et al. 2012) and tannins 
(Ahmadiani et al. 2000). There are also reports on 
alkaloidal analgesic effects (Reanmongkol et al. 2005), 
and with saponins (Choi et al. 2005, Arrau et al. 2010). 
Certain flavonoids possess potent inhibitory activity 
against many enzymes such as protein kinase C, protein 
tyrosine kinases, phospholipase A2 and 
phosphodiesterases (Middleton, 1998). Flavonoids 
were also reported to be effective against inflammation 
(Narayana et al. 2001) by inhibiting enzymes involved 
in prostaglandin synthesis (Kamil, 1993; Kim et al. 
2000).  
Thus, the antinociceptive and anti-inflammatory effect 
exhibited by the plant L. aurita may be due to the 
presence of saponins, flavonoids, alkaloids, 
carbohydrates, tannins or combination of all found 
present in the plant. 
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Data was analyzed using one way ANOVA followed by Bonferoni Post Hoc test and presented as mean 
± SEM, * = p<0.05, ** =p<0.01, *** =P<0.001, **** =P< 0.0001 significant statistical difference as 
compared with Control group, n=6, MELA= methanol extract of L. aurita, PIR = piroxicam 20 mg/kg 
    Figure 1: Effect of methanol extract of L. aurita on acetic acid induced writhing in mice  
 
    Table 1: Effect of the methanol extract of L. aurita on thermally induced pain in mice 
Groups 
(mg/kg) 
Mean reaction time ± SEM (secs)  
0 min 30 mins 60 mins 90 mins 120 mins 
Control  2.29±0.10 2.18±0.22 2.19±0.23 2.43±0.28 2.49±0.19 
LA(200)  1.67±0.14 3.25±0.39 3.32±0.14** 3.01±0.24* 3.02±0.29* 
LA(400)  1.81±0.25 2.82±0.14** 3.02±0.16 3.28±0.31 3.29±0.18 
LA(800)  2.08±0.20 2.99±0.19 2.69±0.19 3.87±0.27** 3.81±0.24** 
Mor (5)  2.15±0.19 3.37±0.20* 3.07±0.41 3.73±0.16* 3.72±0.27* 
Data was analyzed using repeated measures ANOVA followed by Bonferroni post hoc test, * = P< 0.05, ** = P< 0.01 significant statistical 
increase in mean reaction time compared with time zero; n=6. Values are Mean ± SEM. LA= methanol extract of Laggera aurita, Mor = 
morphine 5 mg/kg  
  Table 2: Effect of methanol extract of L. aurita interacted with naloxone and assessed by hot plate test 
Treatment 
(mg/kg)`  
Mean reaction time ± SEM (secs) 
0 mins 60 mins 120 mins 180 mins 
Control  2.09±0.17 2.00±0.14 1.97±0.09 2.04±0.14 
LA (400)  1.75±0.13 1.90±0.13 1.81±0.09 1.69±0.07 
LA (800)  2.16±0.19 1.99±0.21* 2.03±0.19* 1.88±0.18** 
Mor (5)  2.21±0.12 2.13±0.16 2.05±0.11 1.94±0.10* 
Data was analyzed using repeated measures ANOVA followed by Bonferroni post hoc test, * = p<0.01, ** = p<0.001 significant statistical 
difference compared with time zero; n=10. Values are Mean ± SEM. LA= methanol extract of L. aurita, Mor= morphine 5 mg/kg 
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  Table 3: Effect of methanol extract of L. aurita on formalin induced inflammation in rats 
Treatment 
(mg/kg)  
Mean Paw Diameter (millimetre) 
0 hrs 1 hrs 2 hrs 3 hrs 4 hrs 5 hrs 
Control  2.24±0.06 2.78±0.10## 3.18±0.05## 3.4±0.05#### 3.03±0.06#### 2.7±0.06# 
LA  (200)  2.08±0.05 2.76±0.06## 2.73±0.04## 2.88±0.04## 2.57±0.03**## 2.46±0.01*## 
LA  (400)  2.19±0.07 2.86±0.02## 2.87±0.02## 2.86±0.06### 2.65±0.04** 2.34±0.05** 
LA  (800)  2.21±0.09 2.86±0.03# 2.82±0.04# 2.78±0.03## 2.46±0.06** 2.33±0.04** 
Ket  (10)  2.21±0.05 2.55±0.06## 2.69±0.09## 2.32±0.04## 2.3±0.02** 2.19±0.01** 
Data was analyzed using repeated measures ANOVA followed by Bonferoni Post Hoc test, *= p<0.05, **= p<0.0001, significant statistical 
decrease in mean paw edema size (blue) as compared to the peak of edema (red), # = p<0.05, ## = p<0.01, #### = p<0.000 significant 
statistical increase in mean paw diameter as compared to time zero; n= 6. Values are Mean ± SEM. LA= methanol extract of L. aurita, 
Ket= ketoprofen 10 mg/kg, hrs= hours 
 
The oral LD50 was above 5000 mg/kg for MELA, 
showing relative safety. LD50 is a useful index in 
assessing the safety margin of a substance.  The OECD 
(Walum, 1998) classification of acute systemic toxicity 
based oral LD50 of >500 ≤ 2000 mg/kg as non-toxic or 
harmful. Based on this, the oral LD50 greater than 5000 
mg/kg established in both mice and rats indicated 
relative oral safety. Other toxicity scales (Hodge and 
Sterner, 1943) reported that compound with an oral 
LD50 of between 500 – 2000 mg/kg should be 
considered practically non-toxic. 
Acetic acid induced writhing test is usually employed to 
screen for peripheral analgesic activity (Bentley et al. 
1981, Gene et al. 1998). Intraperitoneal administration 
of acetic acid to mice leads to the release of 
prostaglandins like PGE2 and PGF2α which have been 
implicated as mediators of pains and inflammations 
(Santosh et al. 2008). Thus, activity shown by MELA 
suggests that analgesic effects may be due to their 
action on visceral receptors sensitive to acetic acid, or 
inhibition of the production of algogenic substances, or 
the inhibition at the central level of painful messages 
transmission or combination of all the three mentioned 
above. 
The thermally induced pain model is utilized as a 
standard method for the evaluation of centrally 
mediated analgesia. Narcotic agents like morphine, 
pentazocine and codeine mediate their analgesic effect 
through this mechanism (Leonard et al. 2006). The 
analgesic activity observed in MELA may be due to its 
activity via central mechanism similar to the narcotic 
analgesic agents (Vogel and Vogel, 1997).  This centrally 
mediated effect which is through interaction with 
opioid receptors (Leonard et al. 2006) was blocked by 
prior administration of naloxone. Naloxone is a specific 
antagonist of opioid receptors (Stein, 1995, Almeida et 
al. 2011), and thus the inhibition of the analgesic action 
in the presence of this agent suggests possible central 
and opioid receptor involvement in the analgesic effect 
of the plant extract. 
Formalin induced inflammatory response is usually bi-
phasic in nature. The first phase is mainly due to the 
release of histamine, serotonin and kinins (1-3 hours) 
while the second phase is mainly attributed to the 
release of prostaglandins (Vinegar et al. 1969; Chan et 
al. 1995). MELA inhibited both phases of inflammation 
which may be due to its ability to inhibit the release of 
the mediators of inflammation. 
Some analgesic drugs act by inhibiting prostanoids 
biosynthesis. They act as analgesic and anti-
inflammatory agents by inhibiting COX-2 dependent 
prostanoids in the cells at inflammatory sites (Mishra et 
al. 2011) and in the spinal cord (Ramer et al. 1998). 
They also inhibit the action of phospholipase A2, which 
releases arachidonic acid from the cell membrane 
(Burke et al. 2006). These classes of drugs are usually 
associated with side effects like stomach problems such 
as bleeding, ulcer, stomach upset (Traversa et al. 1995), 
kidney problems, heart problems (Gislason et al. 2009), 
high blood pressure and fluid retention (Knight et al. 
2010). Thus, the histological changes observed in the 
organs from animals exposed to 2000 and 5000 mg/kg 
may be resultant from inhibition of prostanoid 
biosynthesis. 
5. Conclusion 
The methanol extract of L. aurita has been shown to 
possess significant analgesic and anti-inflammatory 
activities which may be responsible for it use in painful 
and inflammatory conditions. Based on this, studies 
should be carried out to isolate, characterize and 
elucidate the structure of the bioactive constituents 
responsible for the observed pharmacological effects. 
The results of histological studies showed effects on 
kidney and liver at dose of 2000 mg/kg and on kidney, 
liver, spleen, lungs and stomach at dose of 5000 mg/kg, 
thus detailed toxicological screening on long term 
repeated dosing should be conducted. 
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